Soleo Health tapped to distribute Novartis drug
By HME News Staff
Updated 8:42 AM CDT, Wed July 27, 2022
FRISCO, Texas – Soleo Health, a national provider of complex specialty pharmacy services, has been selected as a limited distribution partner for the cardiovascular drug LEQVIO manufactured by Novartis. “Soleo Health’s expertise in caring for patients with complex conditions and our ability to offer services in the home or alternate sites of care creates additional value for pharmaceutical manufacturers,” said Drew Walk, CEO of Soleo. “We continue to expand our limited distribution partnerships with numerous drug manufacturers as they appreciate our dedication to clinical excellence and high-quality care.” LEQVIO is a subcutaneous injection that Soleo Health will administer to patients in their homes or at one of the company’s ambulatory infusion centers nationwide.
Comments